In 2015 Erik Lefkosky co-founded Tempus, a technology company that seems to consolidate health information of cancer patients. With that information, Lefkosky hopes to make that data useful and accessible to other physicians so they can learn from the data as well. The aim of this is to provide more information so that doctors can make better decisions for their patients in terms of treatments and diagnoses. Tempus collects the date, cleans it up, and makes it useful by analyzing it for algorithms and patterns. Tempus is rapidly becoming one of the most well known medical tech companies and has partnered with several medical organizations that aim to improve cancer outcomes and diagnoses. Those companies send their data to Tempus for analysis and Tempus sends that data back in the form of a report. Once that is completed, the doctors will have access to teh Tempus data which may help them in diagnosing their own patients. One of the ways this is done is by genomic sequencing which adds data on a molecular level. This gives doctors real time information that can be used to help their patients. Tempus could prove especially helpful for patients with Alzheimer’s since it could provide data to help diagnose it sooner, potentially making patient outcomes much more positive.
Erik Lefkosky is an entrepreneur who has founded and co-founded several companies. He graduated from the University of Michigan and earned his Juris Doctor from the University of Michigan Law School. Lefkosky has also authored a book titled Accelerated Disruption: Understanding the True Speed of Innovation.
Lefkosky has a history of giving back to the scientific community and becoming involved with numerous charities which support scientific causes throughout the globe. In addition to being a philanthropist, Lefkosky also serves as an adjunct professor at the University of Chicago’s Booth School of Business.